Aims: To review the outcome of renal transplantation in small children
treated with triple immunosuppression at a single Australian centre.
Methods: The medical records of all children under the age of five yea
rs undergoing renal transplantation from 1988 were reviewed. The durat
ion of follow-up was 30 months (range 18-36). Results: Six children re
ceived seven renal allografts (five living-related [LR] and two cadave
ric [CD]). They had a median age of 3.75 years (range 1.5-4.9) and wei
ght of 11.6 kg (9.1-14.5) at the time of transplantation. All patients
received an immunosuppressive regime involving cyclosporin A, azathio
prine and prednisolone. There were no deaths. The only graft lost was
a CD graft (severe acute rejection within one week of transplantation)
. Hypertension occurred in all recipients and usually required more th
an one antihypertensive drug for treatment. Renal function measured by
serum median creatinine concentration (range) was 0.05 mmol/L (0.03-0
.11) at three months (n = 6) and 0.10 mmol/L (0.07-0.22) at 30 months
(n = 4). Growth estimated from median (range) height standard deviatio
n scores was -1.97 (-1.36--4.04) at three months (n = 6) and -1.90 (-1
.74-2.50) at 30 months (n = 4). No patient was entirely weaned from pr
ednisolone. Cyclosporin A side effects included hirsutism (five patien
ts), gingival hyperplasia (six patients) and nephrotoxicity (three pat
ients). Conclusions: Satisfactory patient and graft survival can be ac
complished in this recipient age group. The results compare with other
international experience and accumulating Australian experience. Hype
rtension and poor skeletal growth were consistent observations. The lo
ng-term outcome of renal function using triple immunosuppression remai
ns to be determined.